TECHNOLOGY
TECHNOLOGY
TECHNOLOGY
INVESTORS
INVESTORS
TECHNOLOGY
RESOURCES
RESOURCES
TECHNOLOGY
TECHNOLOGY
TECHNOLOGY
TECHNOLOGY
RESOURCES
RESOURCES
Improved Therapy Through Continuous Information
Find out how we are transforming the industry by providing continuous, clinically actionable information
News
InjectSense Opens Palo Alto Engineering Office
InjectSense Tapes Out First Silicon for Ultra-Low Power ASIC Blocks
InjectSense Announces Medical Board of Advisors
To be replaced by better photo
of finger/device
Technology
Our smart sensor is a self-anchoring platform that interfaces well with media (blood, tissue, other fluids) without interfering with the electronics that support the sensing, computing and transmission of data.
Investors
InjectSense is funded by angel groups and private investors. It generates revenue from joint development projects with strategic market players, based on derived products from its core sensing technology platform. The company is currently coordinating Series A funding.
Events
COMS Conference
August 28-31, 2016
Houston
Medica
November 14-17, 2016
Dusseldorf
The InjectSense Difference
Take a look at how the company's Silicon Valley and Twin Cities product teams combine cutting-edge advances in microelectronics with best-in-class medical device development and expertise.
CAUTION - Investigational Device. Limited by Federal law to investigational use.